# BioEclipse Therapeutics, Inc. – FDA Inspection, Mar 25, 2025

Source: https://www.keypedia.com/records/fda_inspections/bioeclipse-therapeutics-inc/dc212f11-2dc0-4d60-835a-d37928abaaa0
Source feed: FDA_Inspections

> FDA inspection 1265444 of BioEclipse Therapeutics, Inc., March 25, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1265444
- Company Name: BioEclipse Therapeutics, Inc.
- Inspection Date: 2025-03-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: San Francisco District Office
- Citation Count: 1

## Related Officers

- [Investigator](https://www.keypedia.com/people/joan-t-briones/f3b6554f-1a5c-4266-8a94-6c7488281659)
- [FDA Associated Person](https://www.keypedia.com/people/kristin-m-abaonza/cf909da8-837d-4dfe-9ccc-288b24d7bba3)

Company: https://www.keypedia.com/companies/bioeclipse-therapeutics-inc/9261c9df-d246-4115-a7ed-e660834bd635

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df
